BUDAPEST (Reuters) - Hungary has banned the commercial export of hydroxychloroquine sulfate, an ingredient used in drugs for coronavirus treatment in several countries, the government said on Wednesday.
The ban applies to hydroxychloroquine sulfate and drugs containing the ingredient.
“As Hungary is one of the world’s largest exporters of this ingredient, the protection and medical supply of the Hungarian population is now a priority,” the government said in a statement on its website.
Reporting by Gergely Szakacs and Krisztina Than; Editing by Edmund Blair
Our Standards: The Thomson Reuters Trust Principles.